Tumor-induced changes in host metabolism: A possible role for free tryptophan as a marker of neoplastic disease

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 363-366

  Laviano, Alessandro ^a   Cascino, Antonia ^a   Muscaritoli, Maurizio ^a   Fanfarillo, Francesca ^a   Fanelli, Filippo Rossi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRYPTOPHAN;

BLOOD LEVEL; BREAST CANCER; CANCER SURGERY; CARBOHYDRATE METABOLISM; COLON CANCER; CONFERENCE PAPER; CONTROLLED STUDY; HOST; HUMAN; LIPID METABOLISM; LUNG CANCER; MAJOR CLINICAL STUDY; METABOLISM; NEOPLASM; PRIORITY JOURNAL; PROTEIN METABOLISM; STATISTICAL SIGNIFICANCE; STOMACH CANCER;

EID: 1042279504     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_41     Document Type: Conference Paper

References (17)

1. P.H. Sugarbaker, N.R. Dummick, E.V. Sigarbaker, Diagnosis and staging, in: Cancer, principles and practice of oncology, edited by V.T. De Vita, S. Hellman, S.A. Rosenberg (JB Lippincott, Philadelphia, 1982), pp. 223-230.
2. J.A. Norton, M. Maher, R. Wesley, D. White, M.F. Brennan, Glucose intolerance in sarcoma patients, Cancer 54, 3022-3027 (1984).
3. P.S. Schein, D.D. Kisner, D. Haller, M. Blecher, M. Hamosh, Cachexia of malignancy. Potential role of insulin in nutritional management, Cancer 43, 2070-2076 (1979).
4. K. Lundholm, A.C. Bylund, T. Schersten, Glucose tolerance in relation to skeletal muscle enzyme activities in cancer patients, Scand. J. Clin. Lab. Invest. 37, 267-272 (1977).
5. R.G. Douglas, J.H.F. Shaw, Metabolic effect of cancer, Br. J. Surg. 77, 246-254 (1990).
6. R.T. Chlebowski, L. Bulcavage, M. Grosvenor, et al., Hydrazine sulfate in cancer patients with weight loss. A placeb-controlled clinical experience, Cancer 59, 406-410 (1987).
7. C. Waterhouse, Lactate metabolism in patients with cancer, Cancer 33, 66-71 (1974).
8. C. Waterhouse, N. Jeanpetre, J. Keilson, Gluconeogenesis from alanine in patients with progressive malignant disease, Cancer Res. 39, 1968-1972 (1979).
9. A. Cascino, C. Cangiano, F, Ceci, et al., Plasma amino acid in human cancer: individual role of tumor, malnutrition and glucose toerance, Clin. Nutr. 7, 213-216 (1988).
10. M. Muscaritoli, C. Cangiano, A. Cascino, F. Ceci, L. Giacomelli, P. Cardelli Cangiano, M. Mulieri, F. Rossi Fanelli, Plasma clearance of exogenous lipids in patients with malignant disease. Nutrition 6, 147-151 (1990).
11. J.A. Norton, T.P. Stein, M.F. Brennan, Whole body protein synthesis and turnover in normal man and malnourished patients with and without known cancer, Ann. Surg. 194, 123-128 (1981).
12. R.S. Warren, M. Jeevanandam, M.F. Bennan, Protein synthesis in the tumor-influenced hepatocyte, Surgery 98, 275-282 (1985).
13. K. Lundholm, K. Bennegard, E. Eden, G. Svaninger, P.W. Emery, M.J. Rennie, Efflux of 3-methylhistidine from the leg in cancer patients who experience weight loss, Cancer Res. 42, 4807-4811 (1982).
14. A. Cascino, M. Muscaritoli, C. Cangiano, L. Conversano, A. Laviano, S. Ariemma, M.M. Meguid, F. Rossi Fanelli, Plasma amino acid imbalance in patients with lung and breast cancer, Anticancer Res. 15, 507-510 (1995).
15. F. Rossi Fanelli, C. Cangiano, F. Ceci, R. Cellerino, F. Franchi, E.T. Menichetti, M. Muscaritoli, A. Cascino, Plasma tryptophan and anorexia in human cancer, Eur. J. Cancer Clin. Oncol. 22, 89-95 (1986).
16. C. Cangiano, A. Cascino, F. Ceci, et al., Plasma and CSF tryptophan in cancer anorexia, J. Neural Transm. 81, 225 (1990).
17. A. Cascino, C. Cangiano, F. Ceci, F. Franchi, T. Mineo, M. Mulieri, M. Muscaritoli, F. Rossi Fanelli, Increased plasma free tryptophan levels in human cancer: a tumor related effect? Anticancer Res. 11, 1313-1316 (1991).